Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Switching apparatus and controlling method thereof
Activated carbon cryogels and related methods
Nacelle cover
Distortion compensation device, distortion compensation method, and radio transmitter
Highly detectable pilot structure
Helmet mandible
Pyridylphenyl compounds for inflammation and immune-related uses
  Randomly Featured Patents
Decorative bag making apparatus and method of use
Method of producing glass
Methods and apparatus for determining the port and/or physical location of an IP device and for using that information
Microwave method and system for material inspection
Slot machine card holder
Multiple language capability in an interactive system
Hypercholestrolemia and tendinous injuries
Front-locking swivel ball loudspeaker mount
Golf putter head
Connection acceptance control scheme by obtaining available quality value